Scientists train Patients' own cells to hunt deadly breast cancer

NCT ID NCT05989828

Summary

This early-phase study is testing a personalized cell therapy for advanced triple-negative breast cancer that has returned or stopped responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to recognize cancer, and infuse them back to attack tumors. The main goals are to find a safe dose and understand side effects in about 20 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

Conditions

Explore the condition pages connected to this study.